Business
Sun Pharmaceutical Industries Limited Press Release Jul 29 2026
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Sun Pharma receives approval to manufacture and market semaglutide in Brazil".

About this update from Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Sun Pharma receives approval to manufacture and market semaglutide in Brazil". View Attachment
View stock analysis, news, and events for Sun Pharmaceutical Industries Limited